Latest news about Patel Chem Specialities
Patel Chem Specialities
156.00
+5.35(+3.55%)
Company Performance:
View Company Insights1D+3.55%
1M+45.32%
6M+86.05%
1Y+54.46%
5Y+49.28%
More news about Patel Chem Specialities
15Sept 26
Patel Chem Specialities fixes Sep 18 record date for AGM e-voting
Record date fixed for September 18, 2026. Eligibility for remote e-voting at AGM. Annual General Meeting scheduled for September 25, 2026. Notification issued under SEBI Regulation 42.
01Sept 26
Patel Chem approves director re-appointment, sets AGM for September 25
Re-appointed Mrs. Anshu Bhupesh Patel as director. Fixed AGM date for September 25, 2026. Set record date for AGM as September 18, 2026. Approved FY26 Directors Report and Secretarial Audit Report.
01Sept 26
Patel Chem Specialises AGM seeks approval for ₹65 crore related-party deals
Patel Chem Specialities Limited schedules its 18th AGM for September 25, 2026. Shareholders to approve related-party transactions capped at ₹65 crore. Cost auditor remuneration of ₹1 lakh for FY27 seeks ratification. Mrs. Anshu Patel seeks re-appointment as director after serving since 2011. Remote e-voting window runs from September 22 to September 24, 2026.
01Sept 26
Patel Chem Specialities FY26 Results: Revenue up 31%, net profit rises 19%
Revenue grew 30.6% YoY to ₹1,372.6 crore in FY26. Net profit rose 18.7% to ₹125.5 crore; EBITDA up 20.1%. EBITDA margin contracted to 13.6% from 15.0% in FY25. Company raised ₹58.8 crore via IPO and listed on BSE SME. Net worth jumped to ₹995.0 crore; debt-to-equity fell to 0.15.
22May 26
Patel Chem re-appoints M/s RTBR & Associates as Secretarial Auditor
Patel Chem Specialities Limited re-appoints M/s RTBR & Associates as Secretarial Auditor for FY 2026-27 effective May 22, 2026, following Board approval.
22May 26
Patel Chem appoints B R S & Associates as Cost Auditor for FY 2026-27
PATEL CHEM SPECIALITIES LIMITED has appointed M/s B R S & Associates as Cost Auditor for FY 2026-27 effective May 22, 2026, following Board approval to comply with the Companies Act, 2013 and SEBI regulations.
22May 26
Patel Chem FY26 Net Profit Rises 19% to ₹1,255 Lakh
Patel Chem Specialities Limited reported a 19% increase in FY26 net profit to ₹1,255.22 lakh, supported by a 30.6% rise in revenue from operations to ₹13,726.33 lakh. Total revenue for the year reached ₹13,908.19 lakh, while total expenses were managed at ₹12,209.91 lakh. The board approved the audited financial results, re-appointed statutory and internal auditors for FY27, and confirmed no deviation in IPO fund utilization.
14May 26
Patel Chem Specialities Schedules Board Meeting on May 22, 2026 to Approve FY26 Audited Financial Results
Patel Chem Specialities has scheduled a Board of Directors meeting on May 22, 2026, to approve the Annual Audited Financial Statement and Audited Financial Results for the year ended March 31, 2026. The agenda also includes the reappointment of M/s BIMAL SHAH ASSOCIATES as Internal Auditor, M/s RTBR & Associates as Secretarial Auditor, and the appointment of M/s BRS & Associates as Cost Auditor, all for FY 2026-27. The trading window for the company's securities remains closed from April 1, 2026, and will reopen 48 hours after the declaration of the audited results.
14Apr 26
Patel Chem Specialities Clarifies Recent Share Price Movement as Market-Driven
Patel Chem Specialities Limited clarified to BSE that recent significant share price movements are market-driven and not related to any undisclosed price-sensitive information or corporate developments. The company responded to BSE's April 10, 2026 inquiry, emphasizing it has no role in the price fluctuations and attributing them to external market conditions. The management reaffirmed full compliance with SEBI listing regulations and assured timely disclosure of material events.
14Apr 26
Patel Chem Specialities Submits Quarterly Compliance Certificate to BSE for Q4 FY26
Patel Chem Specialities Limited submitted its quarterly compliance certificate to BSE for the quarter ended March 31, 2026, pursuant to SEBI Depositories Regulation 74(5). The certificate, issued by RTA MUFG Intime India Private Limited, confirms proper handling of dematerialisation processes and adherence to regulatory timelines during the quarter.
14Feb 26
Patel Chem Specialities Submits Q3FY26 IPO Proceeds Monitoring Report
Patel Chem Specialities Limited submitted its Q3FY26 monitoring agency report showing utilization of Rs. 6.29 crore from its Rs. 58.80 crore IPO proceeds raised in July 2025. The company has cumulatively utilized Rs. 22.55 crore with Rs. 36.25 crore remaining in fixed deposits. The primary capital expenditure project for a new specialty chemicals facility at Indrad, Mahesana is progressing as planned with a turnkey agreement worth Rs. 45.00 crore. The monitoring agency reported no deviations from stated objects.
26Nov 25
Patel Chem Specialities Reports Strong H1 FY26 Results with 22% Revenue Growth
Patel Chem Specialities Limited, a manufacturer of cellulose and starch-based pharmaceutical excipients, has reported strong financial results for H1 FY2026. Revenue increased by 22% to ₹61.16 crore, while Profit After Tax (PAT) grew by 17% to ₹6.13 crore. The company is expanding its production capacity with new facilities in Indrad and Vatva. Patel Chem Specialities maintains a strong export presence in over 15 countries with 100% repeat orders across major product lines.
22Sept 25
Patel Chem Specialities Inks Rs 45 Crore Turnkey Project Deal with J & H Pharma Consultants
Patel Chem Specialities Limited has executed an Independent Turnkey Project Service Agreement with J & H Pharma Consultants for their Indrad Plant, valued at Rs 45.00 crores. The project scope includes designing, engineering, procuring, constructing, and testing to deliver a fully operational facility. The plant is located in Mouje Village, Taluka Talod. J & H Pharma Consultants is not related to Patel Chem's promoter or promoter group, ensuring the transaction is not a related party deal.
05Sept 25
Patel Chem Specialities Secures Environmental Clearance for Gujarat Pharmaceutical Plant
Patel Chem Specialities Limited has received environmental clearance from the Ministry of Environment, Forest and Climate Change for its pharmaceutical manufacturing project in Gujarat. The project, located in Mehsana district, will produce APIs and bulk drugs with a capacity of 501 MT/month. The company plans to invest Rs 19.75 crore, including Rs 2.41 crore for environmental pollution control. The facility will create 25 jobs and implement various environmental safeguards, including emission control systems and water management measures.
Industry Peers
Pidilite Industries
SRF
Gujarat Fluorochemicals
Navin Fluorine International
Himadri Speciality Chemical
Deepak Nitrite
Aether Industries
Aarti Industries
Atul
Fine Organic Industries
1,491.90
(-0.38%)
2,486.70
(-0.21%)
4,668.00
(+2.58%)
8,473.00
(+0.06%)
663.35
(+0.51%)
1,647.40
(+1.56%)
1,676.00
(-2.31%)
495.50
(+1.58%)
5,962.50
(-0.59%)
5,513.00
(+1.67%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
